SALEM MEDIA GROUP INC (SALM)

US7940931048 - Common Stock

0.2609  -0.04 (-13.06%)

After market: 0.26 0 (-0.34%)

Fundamental Rating

1

Taking everything into account, SALM scores 1 out of 10 in our fundamental rating. SALM was compared to 96 industry peers in the Media industry. Both the profitability and financial health of SALM have multiple concerns. SALM is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

SALM had negative earnings in the past year.
SALM had a negative operating cash flow in the past year.
SALM had negative earnings in 4 of the past 5 years.
SALM had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

SALM's Return On Assets of -9.71% is on the low side compared to the rest of the industry. SALM is outperformed by 74.74% of its industry peers.
Looking at the Return On Equity, with a value of -34.61%, SALM is doing worse than 73.68% of the companies in the same industry.
The Return On Invested Capital of SALM (0.02%) is worse than 67.37% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SALM is below the industry average of 7.68%.
Industry RankSector Rank
ROA -9.71%
ROE -34.61%
ROIC 0.02%
ROA(3y)-0.97%
ROA(5y)-1.69%
ROE(3y)-6.17%
ROE(5y)-6.92%
ROIC(3y)3.01%
ROIC(5y)3.18%

1.3 Margins

With a Operating Margin value of 0.04%, SALM is not doing good in the industry: 67.37% of the companies in the same industry are doing better.
SALM's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 12.12%, SALM is doing worse than 86.32% of the companies in the same industry.
SALM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.04%
PM (TTM) N/A
GM 12.12%
OM growth 3Y-8.13%
OM growth 5Y-10.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.42%
GM growth 5Y-4.99%

1

2. Health

2.1 Basic Checks

SALM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SALM has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, SALM has more shares outstanding
The debt/assets ratio for SALM has been reduced compared to a year ago.

2.2 Solvency

SALM has an Altman-Z score of 0.25. This is a bad value and indicates that SALM is not financially healthy and even has some risk of bankruptcy.
SALM's Altman-Z score of 0.25 is on the low side compared to the rest of the industry. SALM is outperformed by 73.68% of its industry peers.
A Debt/Equity ratio of 1.15 is on the high side and indicates that SALM has dependencies on debt financing.
SALM has a worse Debt to Equity ratio (1.15) than 68.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF N/A
Altman-Z 0.25
ROIC/WACC0
WACC6.08%

2.3 Liquidity

A Current Ratio of 0.66 indicates that SALM may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.66, SALM is doing worse than 91.58% of the companies in the same industry.
SALM has a Quick Ratio of 0.66. This is a bad value and indicates that SALM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.64, SALM is not doing good in the industry: 91.58% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.64

3

3. Growth

3.1 Past

SALM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -400.00%.
SALM shows a decrease in Revenue. In the last year, the revenue decreased by -2.14%.
SALM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.25% yearly.
EPS 1Y (TTM)-400%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-161.36%
Revenue 1Y (TTM)-2.14%
Revenue growth 3Y1.69%
Revenue growth 5Y0.25%
Revenue growth Q2Q-5.03%

3.2 Future

SALM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.62% yearly.
The Revenue is expected to grow by 3.05% on average over the next years.
EPS Next Y-1178.92%
EPS Next 2Y38.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.18%
Revenue Next 2Y3.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SALM. In the last year negative earnings were reported.
Also next year SALM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SALM.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.36

4.3 Compensation for Growth

SALM's earnings are expected to grow with 38.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.62%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SALM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SALEM MEDIA GROUP INC

NASDAQ:SALM (1/18/2024, 7:22:51 PM)

After market: 0.26 0 (-0.34%)

0.2609

-0.04 (-13.06%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.10M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.71%
ROE -34.61%
ROCE
ROIC
ROICexc
ROICexgc
OM 0.04%
PM (TTM) N/A
GM 12.12%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.66
Quick Ratio 0.64
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-400%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-1178.92%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.14%
Revenue growth 3Y1.69%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y